{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:21:49Z","timestamp":1783387309993,"version":"3.54.6"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.pnpbp.2007.03.015","type":"journal-article","created":{"date-parts":[[2007,4,2]],"date-time":"2007-04-02T11:12:44Z","timestamp":1175512364000},"page":"1139-1140","source":"Crossref","is-referenced-by-count":14,"title":["Venlafaxine and tardive blepharospasm: A case report"],"prefix":"10.1016","volume":"31","author":[{"given":"Yu","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Yee","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chiang","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian-Yoon","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pao-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2007.03.015_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.wnf.0000228806.41420.22","article-title":"Tardive blepharospasm associated with cinnarizine use","volume":"29","author":"Alonso-Navarro","year":"2006","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib2","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/mds.21080","article-title":"Tardive blepharospasm beginning after withdrawal of veralipride","volume":"21","author":"Alonso-Navarro","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib3","first-page":"398","article-title":"Paroxetine and tardive akathisia","volume":"45","author":"Boffa","year":"2000","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00004714-199606000-00016","article-title":"Paroxetine and tardive dyskinesia","volume":"16","author":"Botsaris","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1192\/bjp.187.4.352","article-title":"Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study","volume":"187","author":"Bradwejn","year":"2005","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00003495-200464030-00002","article-title":"Primary blepharospasm: diagnosis and management","volume":"64","author":"Defazio","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00002826-199506000-00001","article-title":"Tardive syndromes and other drug-induced movement disorders","volume":"18","author":"Jankovic","year":"1995","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jnnp.63.3.412a","article-title":"Blepharospasm induced by flunarizine","volume":"63","author":"Koukoulis","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4088\/JCP.v57n1002","article-title":"Movement disorders associated with the serotonin selective reuptake inhibitors","volume":"57","author":"Leo","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00004714-199702000-00020","article-title":"Dystonia associated with trazodone and sertraline","volume":"17","author":"Lewis","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4088\/JCP.v63n0513c","article-title":"Dystonia induced by mirtazapine","volume":"63","author":"Lu","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/mds.870040205","article-title":"Movement disorders and depression due to flunarizine and cinnarizine","volume":"4","author":"Micheli","year":"1989","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.wnf.0000191348.10375.41","article-title":"Dystonic rabbit syndrome from citalopram","volume":"28","author":"Parvin","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib14","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1001\/jama.1982.03320480060028","article-title":"Decongestant-induced blepharospasm and orofacial dystonia","volume":"247","author":"Powers","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib15","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mds.870130614","article-title":"Tardive blepharospasm","volume":"13","author":"Sachdev","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00004714-199902000-00018","article-title":"Dystonia associated with sertraline","volume":"19","author":"Stanislav","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2007.03.015_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archneur.1982.00510190069027","article-title":"Meige's syndrome during long-term dopaminergic therapy in Parkinson's disease","volume":"39","author":"Weiner","year":"1982","journal-title":"Arch Neurol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607001091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584607001091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T12:23:28Z","timestamp":1546950208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584607001091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0278584607001091"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2007.03.015","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}